Omid Hamid

机构：Cedars-Sinai Medical Center, Angeles Clinic and Research Institute · ORCID：0000-0002-8238-4655

发表论文 905 篇 · 总被引 86298 次 · h-index 98

代表论文

• Three-Year Update of a Randomized Phase IIb Study of the Individualized Neoantigen Therapy Intismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab in Resected Melanoma (2026 · JCO oncology advances. · 被引 9)
• Translating ctDNA into cutaneous melanoma care: An international expert survey (2026 · European Journal of Cancer · 被引 3)
• LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial (2026 · Nature Communications · 被引 3)
• Psychometric item/question analysis of multiple-choice questions in fixed prosthodontics exam (2025 · BMC Medical Education · 被引 2)
• A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors (2026 · Clinical Cancer Research)
• Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study (2026 · Clinical Cancer Research)